1. Home
  2. CHMI vs ALDX Comparison

CHMI vs ALDX Comparison

Compare CHMI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.43

Market Cap

95.5M

Sector

Real Estate

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

101.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
ALDX
Founded
2012
2004
Country
United States
United States
Employees
14
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.5M
101.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CHMI
ALDX
Price
$2.43
$1.66
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$3.00
$5.50
AVG Volume (30 Days)
133.3K
986.6K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
15.09%
N/A
EPS Growth
N/A
40.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$61.13
N/A
P/E Ratio
$139.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$1.07
52 Week High
$3.04
$6.18

Technical Indicators

Market Signals
Indicator
CHMI
ALDX
Relative Strength Index (RSI) 28.02 39.25
Support Level $2.40 $1.48
Resistance Level $2.46 $1.88
Average True Range (ATR) 0.06 0.09
MACD -0.02 0.06
Stochastic Oscillator 2.62 47.44

Price Performance

Historical Comparison
CHMI
ALDX

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: